{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T14:36:45Z","timestamp":1793457405127,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008478","name":"Instituto Nacional del Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009559","name":"UNQ","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009559","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021778","name":"ANPCyT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021778","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["PIP 2051"],"award-info":[{"award-number":["PIP 2051"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2017-2056"],"award-info":[{"award-number":["PICT 2017-2056"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2019-2322"],"award-info":[{"award-number":["PICT 2019-2322"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PUNQ 1297-19"],"award-info":[{"award-number":["PUNQ 1297-19"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003947","name":"Universidad Nacional de La Plata","doi-asserted-by":"publisher","award":["X053"],"award-info":[{"award-number":["X053"]}],"id":[{"id":"10.13039\/501100003947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.cbi.2023.110685","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T04:43:56Z","timestamp":1693802636000},"page":"110685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Cu(II)-acylhydrazone complex, a potent and selective antitumor agent against human osteosarcoma: Mechanism of action studies over in vitro and in vivo models"],"prefix":"10.1016","volume":"384","author":[{"given":"Lucia M.","family":"Balsa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisina M.","family":"Solern\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria R.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz S.","family":"Paraj\u00f3n-Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C.","family":"Gonzalez-Bar\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0389-5546","authenticated-orcid":false,"given":"Juan","family":"Garona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1010-3997","authenticated-orcid":false,"given":"Ignacio E.","family":"Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2023.110685_bib1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA","volume":"68","author":"Bray","year":"2018","journal-title":"Cancer J. Clin."},{"key":"10.1016\/j.cbi.2023.110685_bib2","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/jbmr.77","article-title":"Osteosarcoma","volume":"25","author":"Gorlick","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.cbi.2023.110685_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-030-43032-0_1","article-title":"Adjuvant and neoadjuvant chemotherapy for osteosarcoma: a historical perspective","volume":"1257","author":"Benjamin","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.cbi.2023.110685_bib4","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1586\/14737140.2016.1168697","article-title":"Metastatic osteosarcoma: a challenging multidisciplinary treatment","volume":"16","author":"Meazza","year":"2016","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.cbi.2023.110685_bib5","volume":"vol. 64","author":"Moreno","year":"2017"},{"key":"10.1016\/j.cbi.2023.110685_bib6","doi-asserted-by":"crossref","first-page":"615","DOI":"10.4155\/fmc-2017-0317","article-title":"Anticancer metallodrugs: where is the next cisplatin?","volume":"10","author":"Hanif","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.cbi.2023.110685_bib7","doi-asserted-by":"crossref","first-page":"772","DOI":"10.2174\/1389557515666151001142012","article-title":"Ruthenium complexes: an emerging ground to the development of metallopharmaceuticals for cancer therapy","volume":"16","author":"Abid","year":"2016","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.cbi.2023.110685_bib8","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1021\/acs.chemrev.5b00597","article-title":"The next generation of platinum drugs: targeted Pt(II) agents, nanoparticle delivery, and Pt(IV) prodrugs","volume":"116","author":"Johnstone","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.cbi.2023.110685_bib9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrd1691","article-title":"Cellular processing of platinum anticancer drugs","volume":"4","author":"Wang","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cbi.2023.110685_bib10","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2174\/0929867328666211117094550","article-title":"Copper complexes as antitumor agents: in vitro and in vivo evidence","volume":"30","author":"Balsa Lucia M","year":"2023","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.cbi.2023.110685_bib11","doi-asserted-by":"crossref","first-page":"5805","DOI":"10.1021\/acs.jmedchem.7b01689","article-title":"Ru(II) compounds: next-generation anticancer metallotherapeutics?","volume":"61","author":"Thota","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2023.110685_bib12","series-title":"Met. Dev. Action Anticancer Agents","first-page":"469","article-title":"16. Copper complexes in cancer therapy","author":"Denoyer","year":"2018"},{"key":"10.1016\/j.cbi.2023.110685_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules24091761","article-title":"Syntheses and biological studies of Cu(II) complexes bearing bis (pyrazol-1-yl)- and Bis(triazol-1-yl)-acetato heteroscorpionate ligands","volume":"24","author":"Pellei","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2023.110685_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cmdc.202100520","article-title":"Anticancer activity and mechanism of action evaluation of an acylhydrazone Cu(II) complex toward breast cancer cells, spheroids, and mammospheres","volume":"17","author":"Balsa","year":"2022","journal-title":"ChemMedChem"},{"key":"10.1016\/j.cbi.2023.110685_bib15","doi-asserted-by":"crossref","first-page":"110975","DOI":"10.1016\/j.jinorgbio.2019.110975","article-title":"Anticancer and antimetastatic activity of copper(II)-tropolone complex against human breast cancer cells, breast multicellular spheroids and mammospheres","volume":"204","author":"Balsa","year":"2020","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.cbi.2023.110685_bib16","doi-asserted-by":"crossref","first-page":"9812","DOI":"10.1039\/D1DT00869B","article-title":"Anticancer activity of a new copper (II) complex with a hydrazone ligand. Structural and spectroscopic characterization, computational simulations and cell mechanistic studies on 2D and 3D breast cancer cell models","volume":"50","author":"Balsa","year":"2021","journal-title":"Dalton Trans."},{"key":"10.1016\/j.cbi.2023.110685_bib17","first-page":"7531","article-title":"Finding new molecular targets of two copper (II) -hydrazone complexes on triple-negative breast cancer cells using mass-spectrometry-based","author":"Balsa","year":"2023","journal-title":"Quantitative Proteomics"},{"key":"10.1016\/j.cbi.2023.110685_bib18","doi-asserted-by":"crossref","DOI":"10.1039\/D1QI00233C","article-title":"Water-mediated reduction of [Cu(dmp) 2 (CH 3 CN)] 2+ : implications of the structure of a classical complex on its activity as an anticancer drug","author":"Levin","year":"2021","journal-title":"Inorg. Chem. Front."},{"key":"10.1016\/j.cbi.2023.110685_bib19","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1039\/C7DT00283A","article-title":"Copper(ii) thiosemicarbazone complexes induce marked ROS accumulation and promote nrf2-mediated antioxidant response in highly resistant breast cancer cells","volume":"46","author":"S\u00eerbu","year":"2017","journal-title":"Dalton Trans."},{"key":"10.1016\/j.cbi.2023.110685_bib20","doi-asserted-by":"crossref","first-page":"106092","DOI":"10.1016\/j.ejps.2021.106092","article-title":"Antiproliferative activity of two copper (II) complexes on colorectal cancer cell models: impact on ROS production, apoptosis induction and NF-\u03baB inhibition","volume":"169","author":"Ruiz","year":"2022","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.cbi.2023.110685_bib21","doi-asserted-by":"crossref","first-page":"11366","DOI":"10.1002\/chem.201701939","article-title":"Cancer stem cell and bulk cancer cell active copper(II) complexes with vanillin schiff base derivatives and naproxen","volume":"23","author":"Lu","year":"2017","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.cbi.2023.110685_bib22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/anie.201710910","article-title":"A copper(II) phenanthroline metallopeptide that targets and disrupts mitochondrial function in breast cancer stem cells","volume":"57","author":"Laws","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.cbi.2023.110685_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11010-012-1548-8","article-title":"Cu(Nor)2\u00b75H2O, a complex of Cu(II) with Norfloxacin: theoretic approach and biological studies. Cytotoxicity and genotoxicity in cell cultures","volume":"376","author":"Di Virgilio","year":"2013","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.cbi.2023.110685_bib24","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1080\/24701556.2017.1284115","article-title":"Synthesis, characterization, and crystal structures of mononuclear and dinuclear copper(II) complexes derived from similar tridentate Schiff bases","volume":"47","author":"Mei","year":"2017","journal-title":"Inorg. Nano-Metal Chem."},{"key":"10.1016\/j.cbi.2023.110685_bib25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10534-018-0154-y","article-title":"Copper complex with sulfamethazine and 2,2\u2019-bipyridine supported on mesoporous silica microspheres improves its antitumor action toward human osteosarcoma cells: cyto- and genotoxic effects","volume":"32","author":"Cadavid-Vargas","year":"2019","journal-title":"Biometals"},{"key":"10.1016\/j.cbi.2023.110685_bib26","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2174\/1871520616666160513130204","article-title":"Copper(II) complexes with saccharinate and glutamine as antitumor agents: cytoand genotoxicity in human osteosarcoma cells","volume":"17","author":"Cadavid-Vargas","year":"2016","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.cbi.2023.110685_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ica.2018.11.039","article-title":"Synthesis, crystal structure and cytotoxicity assays of a copper(II) nitrate complex with a tridentate ONO acylhydrazone ligand. Spectroscopic and theoretical studies of the complex and its ligand","volume":"487","author":"Burgos-Lopez","year":"2019","journal-title":"Inorg. Chim. Acta."},{"key":"10.1016\/j.cbi.2023.110685_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/inorganics9020009","article-title":"Synthesis, crystal structure, spectroscopic characterization, DFT calculations and cytotoxicity assays of a new Cu(II) complex with an acylhydrazone ligand derived from thiophene","volume":"9","author":"Rodr\u00edguez","year":"2021","journal-title":"Inorganics"},{"key":"10.1016\/j.cbi.2023.110685_bib29","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0014-4827(88)90265-0","article-title":"A simple technique for quantitation of low levels of DNA damage in individual cells","volume":"175","author":"Singh","year":"1988","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.cbi.2023.110685_bib30","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00775-016-1397-0","article-title":"In vitro and in vivo antitumor effects of the VO-chrysin complex on a new three-dimensional osteosarcoma spheroids model and a xenograft tumor in mice","volume":"21","author":"Le\u00f3n","year":"2016","journal-title":"JBIC, J. Biol. Inorg. Chem."},{"key":"10.1016\/j.cbi.2023.110685_bib31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1039\/C7QI00446J","article-title":"Mononuclear Pd(ii) and Pt(ii) complexes with an \u03b1-N-heterocyclic thiosemicarbazone: cytotoxicity, solution behaviour and interaction versus proven models from biological media","volume":"5","author":"Matesanz","year":"2018","journal-title":"Inorg. Chem. Front."},{"key":"10.1016\/j.cbi.2023.110685_bib36","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1039\/c8mt00369f","article-title":"Comparative antitumor studies of organoruthenium complexes with 8-hydroxyquinolines on 2D and 3D cell models of bone, lung and breast cancer","volume":"11","author":"Ruiz","year":"2019","journal-title":"Metallomics"},{"key":"10.1016\/j.cbi.2023.110685_bib32","doi-asserted-by":"crossref","first-page":"115621","DOI":"10.1016\/j.poly.2021.115621","article-title":"Tridentate acylhydrazone copper(II) complexes with heterocyclic bases as coligands. Synthesis, spectroscopic studies, crystal structure and cytotoxicity assays","volume":"213","author":"Burgos-L\u00f3pez","year":"2022","journal-title":"Polyhedron"},{"key":"10.1016\/j.cbi.2023.110685_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/150845","article-title":"Apoptosis and molecular targeting therapy in cancer","volume":"2014","author":"Hassan","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.cbi.2023.110685_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R","article-title":"Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure","volume":"31","author":"Van Engeland","year":"1998","journal-title":"Cytometry"},{"key":"10.1016\/j.cbi.2023.110685_bib35","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2174\/0929867323666160824162546","article-title":"Vanadium, ruthenium and copper compounds: a new class of nonplatinum metallodrugs with anticancer activity","volume":"24","author":"Leon","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.cbi.2023.110685_bib37","doi-asserted-by":"crossref","first-page":"7120","DOI":"10.1039\/C8NJ06274A","article-title":"Cu(ii) and Zn(ii) complexes with a poly-functional ligand derived from: O -vanillin and thiophene. Crystal structure, physicochemical properties, theoretical studies and cytotoxicity assays against human breast cancer cells","volume":"43","author":"Rodr\u00edguez","year":"2019","journal-title":"New J. Chem."},{"key":"10.1016\/j.cbi.2023.110685_bib38","first-page":"726","article-title":"The ubiquitin proteasome pathway (UPP) in the regulation of cell cycle control and DNA damage repair and its implication in tumorigenesis","volume":"5","author":"Tu","year":"2012","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.cbi.2023.110685_bib39","first-page":"33","article-title":"The role of mitochondria in apoptosis induced in vitro","volume":"18","author":"\u010cervinka","year":"1999","journal-title":"Gen. Physiol. Biophys."},{"key":"10.1016\/j.cbi.2023.110685_bib40","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1021\/cr400135x","article-title":"Advances in copper complexes as anticancer agents","volume":"114","author":"Santini","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.cbi.2023.110685_bib41","doi-asserted-by":"crossref","first-page":"7626","DOI":"10.3390\/ijms22147626","article-title":"Copper(II) complexes containing natural flavonoid pomiferin show considerable in vitro cytotoxicity and anti-inflammatory effects","volume":"22","author":"Van\u010do","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2023.110685_bib42","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1007\/s11033-021-06241-z","article-title":"The role of TXNL1 in disease: treatment strategies for cancer and diseases with oxidative stress","volume":"48","author":"Zhao","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.cbi.2023.110685_bib43","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9291683","article-title":"Increased thioredoxin-1 expression promotes cancer progression and predicts poor prognosis in patients with gastric cancer","author":"Shang","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.cbi.2023.110685_bib44","doi-asserted-by":"crossref","first-page":"33242","DOI":"10.1074\/jbc.M202026200","article-title":"Overexpressed human mitochondrial thioredoxin confers resistance to oxidant-induced apoptosis in human osteosarcoma cells","volume":"277","author":"Chen","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2023.110685_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.883297","article-title":"The role of the thioredoxin detoxification system in cancer progression and resistance","volume":"9","author":"Jovanovi\u0107","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.cbi.2023.110685_bib46","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.ccr.2009.02.026","article-title":"Thioredoxin reductase: a target for gold compounds acting as potential anticancer drugs","volume":"253","author":"Bindoli","year":"2009","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.cbi.2023.110685_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13102493","article-title":"Organoruthenium complexes with benzo-fused pyrithiones overcome platinum resistance in ovarian cancer cells","volume":"13","author":"Kladnik","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.cbi.2023.110685_bib48","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1021\/jm300428v","article-title":"Gold(I) carbene complexes causing thioredoxin 1 and thioredoxin 2 oxidation as potential anticancer agents","volume":"55","author":"Schuh","year":"2012","journal-title":"J. Med. Chem."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279723003526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279723003526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T20:43:37Z","timestamp":1736369017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279723003526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":48,"alternative-id":["S0009279723003526"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2023.110685","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cu(II)-acylhydrazone complex, a potent and selective antitumor agent against human osteosarcoma: Mechanism of action studies over in vitro and in vivo models","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2023.110685","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110685"}}